The General and Plastic Surgery Devices Panel of the Food and Drug Administration’s Medical Devices Advisory Committee will meet Feb.20, according to a Federal Register notice.
The committee will discuss and make recommendations regarding the benefits and risks of dermal fillers with new indications for use, such as in the decolletage area.
Public comments are due by March 20. Comments received on or before Jan. 30 will be provided to the committee.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.